Ricovir EM Tablet

Description

Ricovir Em Tablets Overview Ricovir Em, manufactured by Mylan Pharmaceuticals Pvt Ltd, is used to treat the symptoms of HIV infection and as PrEP (pre-exposure prophylaxis) to reduce the risk of contracting HIV through sexual activity. It works by preventing the transmission of HIV in the body. This medicine is formulated using two antiretroviral medications: Emtricitabine and Tenofovir Disoproxil Fumarate. Key Benefits of Ricovir Em This capsule belongs to a group of antiretroviral medicines that help in treating HIV infection. Beyond this, here is a list of all the advantages of the medication: By taking the Ricovir Em capsule, one can reduce the chance of developing Acquired Immunodeficiency Syndrome (AIDS) and other HIV-related illnesses Ricovir Em tablets block the action of certain enzymes (nucleotide and nucleoside reverse transcriptase enzymes) that the virus needs for reproducti

Benefits

Ricovir EM offers several benefits in the management and prevention of HIV infection:

• Helps reduce the viral load in individuals living with HIV

• Slows the progression of the disease and lowers the risk of developing Acquired Immunodeficiency Syndrome (AIDS)

• Strengthens and protects the immune system

• Helps prevent HIV transmission when used correctly as Pre-Exposure Prophylaxis (PrEP)

• Blocks viral replication by inhibiting key enzymes required by the virus

When used alongside safe sexual practices and medical supervision, Ricovir EM can significantly reduce the risk of acquiring or spreading HIV.

Indications and Usage

Ricovir EM Tablets are prescription antiretroviral medicines used for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The medicine is manufactured by Mylan Pharmaceuticals Pvt Ltd and contains a fixed-dose combination of two antiviral agents:

• Emtricitabine

• Tenofovir Disoproxil Fumarate

Ricovir EM is commonly prescribed for:

• Treatment of HIV-1 infection in combination with other antiretroviral medicines

• Pre-Exposure Prophylaxis (PrEP) to reduce the risk of HIV infection in individuals at high risk

• Helping control viral replication and supporting immune system function

This medication does not cure HIV infection but helps control the virus and reduce complications related to the disease.

How it Works

Ricovir EM contains two antiretroviral drugs — Emtricitabine and Tenofovir Disoproxil Fumarate — which belong to a class of medicines known as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).

These medicines work by:

• Blocking the reverse transcriptase enzyme required for HIV replication

• Preventing the virus from multiplying in the bloodstream

• Reducing the amount of HIV present in the body

• Protecting the immune system from damage

Although Ricovir EM helps control HIV infection, it does not eliminate the virus from the body and does not prevent other sexually transmitted infections.

Dosage & Administration

Ricovir EM should be taken exactly as prescribed by a healthcare provider.

For Treatment of HIV Infection

Adults and children weighing 35 kg or more

• One tablet once daily

• Each tablet contains 200 mg Emtricitabine + 300 mg Tenofovir

Children weighing 17–35 kg

• Dosage must be determined by a doctor

• The child should be able to swallow the tablet whole

Weight-based dosing may include:

• 28–35 kg: 167 mg Emtricitabine + 250 mg Tenofovir daily

• 22–28 kg: 133 mg Emtricitabine + 200 mg Tenofovir daily

• 17–22 kg: 100 mg Emtricitabine + 150 mg Tenofovir daily

For HIV Prevention (PrEP)

Adults and children weighing 35 kg or more may take:

• One tablet daily (200 mg Emtricitabine + 300 mg Tenofovir)

How to Take

• Take the tablet orally with water

• Swallow whole; do not crush or chew

• May be taken with or without food

• Taking it with food may help reduce stomach discomfort

Side Effects

Like many medications, Ricovir EM may cause side effects in some individuals. Most reactions are mild and temporary, but medical advice should be sought if symptoms persist.

Common Side Effects

• Fever

• Body aches or pain

• Nasal congestion or runny nose

• Sore throat

• Skin redness or rash

• Fatigue or weakness

• Sinus discomfort or facial tenderness

Less Common Side Effects

• Tingling or numbness in the hands or feet

• Burning sensation in the face or mouth

• Chest pain

• Coordination difficulties

• Vision disturbances

Serious Side Effects

In rare cases, serious reactions may occur, including:

Kidney Problems

Seek medical attention if you experience:

• Reduced urination

• Swelling in the legs or ankles

• Shortness of breath

• Severe fatigue

• Persistent nausea

Immune System Changes

Symptoms may include:

• Fever or chills

• Swollen lymph nodes

• Persistent cough

• Skin rashes or lesions

• Muscle weakness or coordination problems

Contact a healthcare professional immediately if severe side effects occur.

Warning and Precaution

Before using Ricovir EM, inform your healthcare provider about your medical history and any medications you are currently taking.

Important precautions include:

• Patients with kidney problems should use this medicine with caution

• Regular monitoring of kidney function may be required

• This medicine does not prevent other sexually transmitted infections (STIs)

• Avoid taking multiple doses to compensate for a missed dose

Ricovir EM may interact with certain medicines, including:

• Other HIV treatments

• Hepatitis C medications

• Aminoglycoside antibiotics such as amikacin or gentamicin

• Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen

Always consult a healthcare provider before combining medications.

Patient Guidance

Patients using Ricovir EM should follow these guidelines:

• Take the medicine at the same time each day for best results

• Do not skip doses, as this may reduce effectiveness

• Continue using safe sexual practices to prevent HIV transmission

• Attend regular medical checkups and laboratory tests

• Inform your doctor if you experience unusual symptoms

Ricovir EM works best when used as part of a complete HIV management plan under medical supervision.

Clinical Trial & Approvals

The combination of Emtricitabine and Tenofovir Disoproxil Fumarate has been widely studied in clinical trials for both HIV treatment and prevention.

Clinical research has demonstrated that:

• The combination significantly reduces HIV viral load in infected patients

• Daily use as Pre-Exposure Prophylaxis (PrEP) can reduce the risk of HIV infection in high-risk individuals

• The therapy is generally well tolerated when used under medical supervision

This drug combination has received regulatory approval for HIV treatment and prevention in multiple countries based on extensive clinical evidence.

References

• https://www.drugs.com/cdi/emtricitabine-and-tenofovir-disoproxil-fumarate.html

• https://my.clevelandclinic.org/health/drugs/18772-emtricitabine-tenofovir-disoproxil-fumarate-tablets

• https://www.mayoclinic.org/drugs-supplements/emtricitabine-and-tenofovir-oral-route/description/drg-20061833

• https://www.webmd.com/drugs/2/drug-91482/emtricitabine-tenofovir-disoproxil-fumarate-truvada/details
• https://www.medicalnewstoday.com/articles/325820

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult a qualified healthcare professional before starting or changing any medication.